China’s biotech moment ignites a 60% stock rally that beats AI
China’s biotechnology stocks have shaken off a four-year slump to be among the hottest performers in Asia this year and ...
China’s biotechnology stocks have shaken off a four-year slump to be among the hottest performers in Asia this year and ...
Published Tue, Jun 3, 2025 · 07:45 AMMERCK has held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than ...
Sanofi agreed to buy Blueprint Medicines for at least US$9.1 billion as the French drugmaker expands further in rare immunological ...
Singapore biotech start-up Mirxes launched its initial public offering (IPO) in Hong Kong on Thursday (May 15) as it seeks ...
Singapore biotech start-up Mirxes launched its initial public offering (IPO) in Hong Kong on Thursday (May 15) as it seeks ...
Biotechnology company Nuevocor announced on Wednesday (May 7) that it completed a US$45 million Series B funding round from new ...
A federal jury has convicted the accused mastermind behind a murder-for-hire plot of all charges brought against him in the ...
The Danish drugmaker alleges misrepresentations by KBP Biosciences founder Huang Zhenhua about the success of its kidney drug PHARMA giant ...
High-growth companies in the technology, healthcare and sustainability-linked industries are potential entrants, tooMARKET watchers believe tax incentives proposed by the ...
High-growth companies in the technology, healthcare and sustainability-linked industries are potential entrants, tooMARKET watchers believe tax incentives proposed by the ...
Forbes 40under40 stands as a distinguished platform revered for its commitment to honoring and applauding the remarkable achievements of exceptional individuals who have yet to reach the age of 40. This esteemed initiative serves as a beacon of inspiration, spotlighting trailblazers across various industries and domains, showcasing their innovation, leadership, and impact on a global scale.
© 2024 Forbes 40under40. All Rights Reserved.